Literature DB >> 497948

Treatment of polycythemia vera.

B K MacDougall, B H Weinerman, S Kemel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 497948      PMCID: PMC1704415     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  13 in total

1.  A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES.

Authors:  E A GEHAN
Journal:  Biometrika       Date:  1965-06       Impact factor: 2.445

Review 2.  POLYCYTHEMIA VERA AND LEUKEMIA--THE ROLE OF RADIATION TREATMENT. A STUDY OF 1222 PATIENTS.

Authors:  B MODAN; A M LILIENFELD
Journal:  Medicine (Baltimore)       Date:  1965-07       Impact factor: 1.889

3.  POLYCYTHEMIA VERA: AGE RELATIONSHIPS AND SURVIVAL.

Authors:  E E OSGOOD
Journal:  Blood       Date:  1965-09       Impact factor: 22.113

4.  Complications and causes of death in polycythaemia vera.

Authors:  E CHIEVITZ; T THIEDE
Journal:  Acta Med Scand       Date:  1962-11

5.  Maximum utilization of the life table method in analyzing survival.

Authors:  S J CUTLER; F EDERER
Journal:  J Chronic Dis       Date:  1958-12

6.  Polycythemia vera. II. Course and therapy.

Authors:  P CALABRESI; O O MEYER
Journal:  Ann Intern Med       Date:  1959-05       Impact factor: 25.391

7.  The incidence of cancer in chronic leukemia and in polycythemia vera.

Authors:  J H LAWRENCE; W G DONALD
Journal:  Am J Med Sci       Date:  1959-04       Impact factor: 2.378

8.  The treatment of polycythemia vera.

Authors:  L R Wasserman
Journal:  Semin Hematol       Date:  1976-01       Impact factor: 3.851

9.  Polycythaemia vera terminating in acute leukaemia. A clinical, cytogenetic and morphologic study in 8 patients treated with alkylating agents.

Authors:  A Weinfeld; J Westin; B Ridell; B Swolin
Journal:  Scand J Haematol       Date:  1977-09

10.  Vascular occlusive episodes and venous haematocrit in primary proliferative polycythaemia.

Authors:  T C Pearson; G Wetherley-Mein
Journal:  Lancet       Date:  1978-12-09       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.